secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2021-11-08T23:59:59+00:00
Accession:  0001459839-21-000059
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE Q3 record revenue $22.3M (+9% YoY); net loss $15.9M; FY21 guidance $89-90M
--------------------------------------------------------------------------------

- Q3 worldwide revenue $22.3M, up 9% YoY; U.S. revenue $20.4M (+8%), international $1.9M (+31%).
- Gross margin improved to 89% (87% YoY); operating loss widened to $13.2M from $8.7M.
- Net loss $15.9M ($0.48/sh) vs $9.5M ($0.33/sh); includes $1.8M debt extinguishment costs.
- Received UnitedHealthcare exclusive iFuse coverage for SI Joint Fusion, covering ~160M U.S. lives.
- FY2021 revenue guidance updated to ~$89-90M (21-23% growth); cash and securities $160.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983921000059/0001459839-21-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983921000059/sibn-20211108.htm
  HTML page:      https://secwatch.observer/filing/0001459839-21-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer